Suh Hyunsuk, Ficarro Scott B, Kang Un-Beom, Chun Yujin, Marto Jarrod A, Buratowski Stephen
Department of Biochemical Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology and Blais Proteomics Center, Dana Farber Cancer Institute, Boston, MA 02115, USA.
Department of Biochemical Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Mol Cell. 2016 Jan 21;61(2):297-304. doi: 10.1016/j.molcel.2015.12.021.
Dynamic interactions between RNA polymerase II and various mRNA-processing and chromatin-modifying enzymes are mediated by the changing phosphorylation pattern on the C-terminal domain (CTD) of polymerase subunit Rpb1 during different stages of transcription. Phosphorylations within the repetitive heptamer sequence (YSPTSPS) of CTD have primarily been defined using antibodies, but these do not distinguish different repeats or allow comparative quantitation. Using a CTD modified for mass spectrometry (msCTD), we show that Ser5-P and Ser2-P occur throughout the length of CTD and are far more abundant than other phosphorylation sites. msCTD extracted from cells mutated in several CTD kinases or phosphatases showed the expected changes in phosphorylation. Furthermore, msCTD associated with capping enzyme was enriched for Ser5-P while that bound to the transcription termination factor Rtt103 had higher levels of Ser2-P. These results suggest a relatively sparse and simple "CTD code."
在转录的不同阶段,RNA聚合酶II与各种mRNA加工和染色质修饰酶之间的动态相互作用是由聚合酶亚基Rpb1的C末端结构域(CTD)上不断变化的磷酸化模式介导的。CTD重复七聚体序列(YSPTSPS)内的磷酸化主要通过抗体来确定,但这些抗体无法区分不同的重复序列,也不能进行比较定量。使用经过质谱修饰的CTD(msCTD),我们发现Ser5-P和Ser2-P在CTD全长均有出现,且比其他磷酸化位点丰富得多。从几种CTD激酶或磷酸酶发生突变的细胞中提取的msCTD显示出预期的磷酸化变化。此外,与加帽酶相关的msCTD富含Ser5-P,而与转录终止因子Rtt103结合的msCTD具有更高水平的Ser2-P。这些结果表明存在一种相对稀疏且简单的“CTD编码”。